PanGIA
PanGIA Biotech provides non-invasive urine liquid biopsy to detect cancer earlier. It uses AI/ML-driven biomolecular profiling to analyze urine samples. Operates as a SaaS platform serving patients and clinicians. The pipeline covers multiple cancers including prostate, breast, ovarian, and lung, aiming for faster, more accessible insights. The company holds ISO certifications and is pursuing FDA approval while operating globally.
PanGIA
PanGIA Biotech provides non-invasive urine liquid biopsy to detect cancer earlier. It uses AI/ML-driven biomolecular profiling to analyze urine samples. Operates as a SaaS platform serving patients and clinicians. The pipeline covers multiple cancers including prostate, breast, ovarian, and lung, aiming for faster, more accessible insights. The company holds ISO certifications and is pursuing FDA approval while operating globally.